The Immunomodulation Effect of Blood Transfusion in Operative Spine Surgery Patients
NCT ID: NCT02069210
Last Updated: 2014-02-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
40 participants
OBSERVATIONAL
2014-05-31
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Immunomodulation Effect of Blood Transfusion
NCT02140216
Transfusion-Induced Alterations of Pulmonary and Immune Function in Mechanically Ventilated Patients
NCT00751322
Effects of Blood Transfusion in Healthy Volunteers
NCT01226498
Conditioning Regimen Before Infusion of Allogeneic Hematopoietic Stem Cells
NCT00770523
Granulocyte Transfusion Study
NCT00000581
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Blood transfusion
Patients receive blood transfusion during operation
Blood transfusion
Intraoperative blood transfusion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood transfusion
Intraoperative blood transfusion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients underwent elective spine surgery
* ASA classification 1-3
Exclusion Criteria
* Cancer
* History of heart disease including, heart failure, coronary artery disease, hypertension treated with more than one medicament.
* Serum creatinine \> 1.5 mg/dL
* Stroke, neurologic and mental deficits, epilepsy
* General or local infection (site of surgery),
* Coagulation disorders.
* Intraoperative massive bleeding
* Infection of the spine
* Rheumatoid arthritis
* Patients who had either of the following drug (aspirin, methotrexate, cyclosporine, qualaquin)
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wolf-Schleinzer-Stiftung
UNKNOWN
Mahidol University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sirilak Suksompong
Associated Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sirilak Suksompong, MD
Role: STUDY_DIRECTOR
Department of Anesthesiology, Faculty of medicine Siriraj Hospital, Mahidol University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sirilak Suksompong
Bangkok, , Thailand
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SI 1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.